SAN FRANCISCO, Jan. 15, 2020 (GLOBE NEWSWIRE) -- Imagin Medical Inc. (IME:CSE; IMEXF:OTCQB) is developing technology that can greatly improve the ability to visualize cancer during minimally invasive surgeries. Its i/Blue Imaging™ System is in development for use in bladder cancer, the sixth most common cancer in the United States. The company has just hit the significant milestone of completing design verification for the system.
Company Mentioned: Imagin Medical Inc.
The company and its technology have caught the attention of two industry observers.
Chris Temple, editor and publisher of The National Investor, writes that Imagin Medical's "disruptive technology is poised to deliver the most significant advancement in bladder cancer detection and removal in decades, making the detection and removal of cancer FAR more efficient and effective."
Technical analyst Clive Maund, writing in CliveMaund.com on January 7, stated, "We were accumulating Imagin Medical stock last fall, most recently in November, and the good news is that it has just staged a dramatic breakout, almost doubling in the last three trading days, or just since the start of the year."
Continue reading this article: Two Analysts See Company as a Buy for 'Game-Changing' Potential in Bladder Cancer Detection and Surgery
About Streetwise Reports
Streetwise Reports shares investment ideas in many sectors. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
DISCLOSURE:
The following companies mentioned in this article are billboard sponsors of Streetwise Reports: Imagin Medical. Click here for important disclosures about sponsor fees. As of the date of this article, an affiliate of Streetwise Reports has a consulting relationship with Imagin Medical. Please click here for more information. An affiliate of Streetwise Reports is conducting a digital media marketing campaign for this article on behalf of Imagin Medical. Please click here for more information. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Imagin Medical, a company mentioned in this article.
The full disclosure is provided at the article's end: Two Analysts See Company as a Buy for 'Game-Changing' Potential in Bladder Cancer Detection and Surgery